Osiris Therapeutics said it has received approval from Health Canada to market its stem cell therapy Prochymal for the treatment of acute graft-vs-host disease in children.
Daniel S. Levine
Advertisement
Articles by Daniel S. Levine
Advertisement
Latest Updated Articles
Osiris Wins Canadian Approval for World's First Stem Cell DrugPublished: May 21st 2012 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
M. Peter Marinkovich, MD, on Integrating Gene Therapy into Clinical Practice for Dermatologists
2
Quarter Century Update: The Continued Unknowns of Cell and Gene Therapy
3
Quarter Century Update: Platform Approaches and Industry Investment
4
